Skip to content

With the Ziyinrunqiao particles in the treatment of vaginal dryness (Liver and kidney Yin deficiency type) middle-aged and old women 150 cases of clinical curative effect evaluation research

With the Ziyinrunqiao particles in the treatment of vaginal dryness (Liver and kidney Yin deficiency type) middle-aged and old women 150 cases of clinical curative effect evaluation research

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IOR-17012792
Enrollment
Unknown
Registered
2017-09-25
Start date
2017-10-09
Completion date
Unknown
Last updated
2017-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vaginal dryness

Interventions

Experimental group :Chinese medicine
Positive control group :Western medicine
Blank control group :nothing

Sponsors

Teaching Hospital of Chengdu University of TCM
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. In the Chengdu University of Traditional Chinese Medicine Affiliated Hospital gynecological clinic treatment, which meets the criteria of vaginal dryness diagnosis, Conform to the diagnostic standard of liver and kidney yin deficiency in TCM; 2. Middle-aged and elderly women between 40 and 65 years; 3. There are follow-up conditions, sign informed consent participate in this study voluntarily.

Exclusion criteria

Exclusion criteria: 1. After the examination of B ultrasound, colposcopy, cervical fluid base cells and vaginal secretions, the diagnosis was of organic disease; 2. After examination, it was diagnosed as reproductive tract infection and other gynecological diseases; 3. Having primary heart, liver, lung, kidney, blood, endocrine, breast and other diseases, or serious diseases affecting its survival, such as tumor or AIDS; 4. In 3 to 6 months, the use of the adjunitin drug supplement therapy, including the use of the hormone ring; 5. Used vaginal medication in 1 month; 6. Allergic constitution; For two or more drugs or food allergies; Or allergic to known ingredients of this drug; 7. Patients with disabilities (blind, deaf, dumb, mental retardation, mental disorders, physical disability) in the law, lack of research compliance and impact assessment; 8. Patients participating in other drug clinical trials.

Design outcomes

Primary

MeasureTime frame
symptom;Vaginal pH;Vaginal health score;E2;

Countries

China

Contacts

Public ContactXIE Ping

Teaching Hospital of Chengdu University of TCM

fxp2410@126.com+86 18981885625

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026